NCT04902105View on ClinicalTrials.gov

Drug-Drug Interaction Study to Evaluate the Effect of Inhibition of UGTs on the PK of Ecopipam and Its Active Metabolite

PHASE1CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

May 13, 2021

Primary Completion Date

July 6, 2021

Study Completion Date

July 6, 2021

Conditions
Drug Interaction
Interventions
DRUG

ecopipam HCL

oral tablets

DRUG

Mefenamic acid

oral capsules

DRUG

Divalproex Sodium ER

oral tablets

Trial Locations (1)

33136

Syneos Health Clinical Research Services, LLC., Miami

Sponsors

Collaborators (1)

Syneos Health
All Listed Sponsors
collaborator

Syneos Health

OTHER

collaborator

Nuventra, Inc.

INDUSTRY

lead

Emalex Biosciences Inc.

INDUSTRY